Get notified when MMED files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Retainer Ring Litigation (new) — 28 lawsuits filed on behalf of 109 individuals, with a recent $253,000 jury verdict and $20 million accrued; about 2,000 additional claimants may exist.
- Blackstone Royalty Obligation (new) — A one-time $157 million charge was recorded for future minimum royalty payments to Blackstone following MiniMed Flex approval.
- Cgm Pricing Pressure (new) — The company observes global pricing pressure on CGMs, particularly in international markets, which could hurt margins.
revenue $843.0M, net income $0. MiniMed's first standalone quarter: sales up 17%, breakeven net income, but margin pressure and litigation loom
Filed September 8, 2026 · Period ending July 31, 2026 · ~1 min read
Key Changes
-
high
Net sales rose 17% to $843 million, driven by international growth, U.S. MiniMed Flex launch, and higher CGM attachment; organic growth was 16%.
MD&A: Revenue verify on EDGAR → -
high
Gross margin fell 1.5 points to 55.1% as lower-margin Simplera sensors became a larger share of sales; CGM pricing pressure is expected to continue.
MD&A: Gross Margin verify on EDGAR → -
high
Net income attributable to the company was breakeven, compared to a loss a year earlier, helped by a favorable swing in litigation charges.
Notes: Profitability view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.
Partner
Trade MMED commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 8, 2026 · How we verify